Volume | 90,085 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 0.869 | Mínimo Máximo |
|||||
Minimo del Dia | 0.83 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
ABVC BioPharma Inc | ABVC | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
0.8364 | 0.83 | 0.869 | 0.859 | 0.83 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
654 | 90,085 | US$ 0.8472362 | US$ 76,323 | - | 0.6739 - 6.87 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
16:15:10 | 73 | US$ 0.8447 | USD |
Información Financiera ABVC BioPharma Inc ABVC
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
9.08M | 10.56M | - | 152k | -10.52M | -1.00 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre ABVC BioPharma Inc ABVC
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
24/5/2024 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
23/5/2024 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
23/5/2024 | 15:30 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
22/5/2024 | 16:00 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
22/5/2024 | 13:31 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
17/5/2024 | 16:00 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
17/5/2024 | 15:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
15/5/2024 | 16:00 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
15/5/2024 | 08:00 | Edgar (US Regulatory) | Form 8-K - Current report |
09/5/2024 | 08:27 | Edgar (US Regulatory) | Form 8-K - Current report |
18/4/2024 | 08:25 | GlobeNewswire Inc. | AiBtl BioPharma Inc. Acquired TT Life Company, Valued at.. |
17/4/2024 | 08:00 | GlobeNewswire Inc. | ABVC BioPharma Executes a Global Licensing Definitive.. |
Histórico de Datos ABVC
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.789 | 0.87 | 0.75 | 0.8211935 | 137,706 | 0.07 | 8.87% |
1 Month | 1.07 | 1.10 | 0.75 | 0.8967909 | 163,524 | -0.211 | -19.72% |
3 Months | 1.07 | 1.73 | 0.75 | 1.28 | 1,245,417 | -0.211 | -19.72% |
6 Months | 1.10 | 2.45 | 0.75 | 1.61 | 1,467,249 | -0.241 | -21.91% |
1 Year | 6.105 | 6.87 | 0.6739 | 1.92 | 1,583,043 | -5.25 | -85.93% |
3 Years | 33.20 | 116.883 | 0.6739 | 17.54 | 992,014 | -32.34 | -97.41% |
5 Years | 33.20 | 116.883 | 0.6739 | 17.54 | 992,014 | -32.34 | -97.41% |